Art. 37
Classification, Labelling and Packaging Regulation · 32008R1272 · every event for this act · on EUR-Lex
3 changes recorded across 3 events, newest first.
in force 2026-07-01 MODIFIED±0§
Amended by Regulation (EU) 2024/2865 32024R2865
applies from: unknown
Sources disagree — the amending act's instructions found this change; the text comparison finds no difference in the provision's text and the EU's own amendment metadata does not list it. All are shown; none is overruled.
No explanation shipped — the structural diff did not see this change, so it carries no text; another signal named the unit and the disagreement ships as `disputed`.
text before / after
No text on either side: this unit was named by a signal that carries no text, and only the structural diff carries any.
in force 2024-12-10 MODIFIED§
Amended by Regulation (EU) 2024/2865 32024R2865
applies from: unknown (the text changed beyond its dates, so no date that moved can be read as the application date)
dates added to the text: 2013-09-01, 2025-06-11, 2026-06-11, 2030-06-11, 2032-06-11 · dates removed: 2015-05-31
The provision now allows proposals for harmonised classification and labelling to cover a group of substances as well as an individual substance, adds acute toxicity estimates alongside concentration limits and M-factors, and gives the Commission a route to request the Agency or the European Food Safety Authority to prepare such a proposal.
New paragraphs on prioritising groups of substances, on the Agency and Authority offering scientific advice on their own initiative, and on a notification and publication procedure before a proposal is submitted have been added, and the fee for proposals under Article 36(3) is now set by an implementing act under the examination procedure rather than by the earlier regulatory procedure.
Paragraph 5 no longer requires a corresponding Table 3.2 entry until 31 May 2015 and instead sets a timing expectation for the Commission's delegated acts, while a new paragraph 7 introduces detailed rules and dates (1 September 2013, 11 June 2025, 11 June 2026, 11 June 2030 and 11 June 2032) for including substances with endocrine-disrupting, PBT or vPvB properties in Table 3 of Part 3 of Annex VI, and a new paragraph 8 addresses grouping criteria for proposals concerning a group of substances.
Cited: Art. 37, v2 · Art. 37, v1
text before / after, on the event page →
in force 2019-07-26 MODIFIED§
Amended by Regulation (EU) 2019/1243 32019R1243
applies from: unchanged
Sources disagree — the text comparison and the EU's own amendment metadata found this change; the amending act's instructions do not mention it. All are shown; none is overruled.
Paragraph 5 no longer describes the Commission submitting a draft decision to amend Table 3.1 of Part 3 of Annex VI through the regulatory procedure with scrutiny, but instead describes it adopting delegated acts under Article 53a to make that amendment.
The reference to the urgency procedure under Article 54(4) is replaced with a reference to the procedure under Article 53b applying to delegated acts adopted under this paragraph in cases of imperative grounds of urgency.
Cited: Art. 37, v1 · Art. 37, v2
text before / after, on the event page →